| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/12/2009 | US20090041770 Fc VARIANTS WITH ALTERED BINDING TO FcRn |
| 02/12/2009 | US20090041768 Modified Fc molecules |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041765 Modified immunoglobulins for use in prevention and treatment of autoimmune or inflammatory diseases |
| 02/12/2009 | US20090041758 Modified binding molecules comprising connecting peptides |
| 02/12/2009 | US20090041756 121p1f1: a tissue specific protein highly expressed in various cancers |
| 02/12/2009 | US20090041755 Methods and Compositions For PDGF-D Activation and Inhibition |
| 02/12/2009 | US20090041749 Compositions and methods for the diagnosis and treatment of tumor |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | US20090041718 Methods of Modulating Cytokine Activity; Related Reagents |
| 02/12/2009 | US20090041717 High affinity human antibodies to human nerve growth factor |
| 02/12/2009 | US20090041679 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | US20090041659 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 02/12/2009 | DE102004059357B4 Antikörper, welcher die Interaktion von humanem Thy-1 und dessen Liganden blockiert, sowie dessen Verwendung Antibody that blocks the interaction of human Thy-1 and its ligands, and its use |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2694751A1 Therapeutic use of anti-tweak receptor antibodies |
| 02/12/2009 | CA2694434A1 Treatment of prion protein related diseases |
| 02/12/2009 | CA2693464A1 Anti-cd37 antibodies |
| 02/12/2009 | CA2663580A1 Bioactive peptides and method of using same |
| 02/11/2009 | EP2022854A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue |
| 02/11/2009 | EP2022846A1 Method for isolation of stem cell |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2022799A2 Polycistronic expression of antibodies |
| 02/11/2009 | EP2022507A1 Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy |
| 02/11/2009 | EP2021799A2 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
| 02/11/2009 | EP2021477A2 Genetic markers for high oleic acid content in plants |
| 02/11/2009 | EP2021474A2 Rage fusion proteins, formulations, and methods of use thereof |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP2021397A2 Methods for site-specific pegylation |
| 02/11/2009 | EP2021373A1 Vcam-1 specific monoclonal antibody |
| 02/11/2009 | EP2021372A2 Compositions and methods for modulating immune responses |
| 02/11/2009 | EP2021371A2 Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cells |
| 02/11/2009 | EP2021370A1 Trail receptor-binding agents and uses of the same |
| 02/11/2009 | EP2021359A1 Enzymes for degrading herbicides |
| 02/11/2009 | EP2021033A2 Il-1 immunization induces autoantibodies protective against atherosclerosis |
| 02/11/2009 | EP2021029A2 Humanized fc riib-specific antibodies and methods of use thereof |
| 02/11/2009 | EP2021027A2 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders |
| 02/11/2009 | EP2021016A2 Cxcl13 antagonists and their use for the treatment of inflammatory diseases |
| 02/11/2009 | EP1841870A4 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 02/11/2009 | EP1747262A4 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | EP1042466B1 Polypeptides, polynucleotides and uses thereof |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |
| 02/11/2009 | EP0879244B1 Mycoplasma recombinant polypeptide and vaccines |
| 02/11/2009 | EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| 02/11/2009 | CN101365799A Method for preparing antibodies selective for activating Fc receptors |
| 02/11/2009 | CN101365723A Antibodies directed to her-3 and uses thereof |
| 02/11/2009 | CN101365722A Methods of purifying anti a beta antibodies |
| 02/11/2009 | CN101365721A Methods for cyclic nucleotide determination |
| 02/11/2009 | CN101365720A Fully human hybridoma fusion partner cell lines |
| 02/11/2009 | CN101365718A Vascular aging-predicting factor and utilization of the same |
| 02/11/2009 | CN101365717A Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said non-diffusible A-beta oligomers and a process for manufacturing of said antibodies |
| 02/11/2009 | CN101365487A Method for treating joint damage |
| 02/11/2009 | CN101362802A DNA dependent protein kinase catalytic subunit single-chain antibody and its encoding gene and application |
| 02/11/2009 | CN101362801A Rapid detection test strip for detecting campylobacter jejuni specific antigen |
| 02/11/2009 | CN101362800A Test strip for rapid detection of brucella |
| 02/11/2009 | CN101362798A Candida albicans hyphal development inhibitor and application thereof |
| 02/11/2009 | CN101362796A B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 02/11/2009 | CN101362795A B cell epitope of epididymal protease inhibitor and antigen peptides containing thereof |
| 02/11/2009 | CN101362794A B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 02/11/2009 | CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 02/11/2009 | CN100460509C Trichina paramyosin gene and application thereof |
| 02/11/2009 | CN100460421C Immunoglobulin variants and uses thereof |
| 02/10/2009 | US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 02/10/2009 | US7488808 Janus family kinases and identification of immune modulators |
| 02/10/2009 | US7488807 Monoclonal antibody for detecting staphylococcal infection |
| 02/10/2009 | US7488805 Apoptosis proteins |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488802 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 02/10/2009 | US7488799 Prostaglandin receptor protein |
| 02/10/2009 | US7488796 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins |
| 02/10/2009 | US7488795 PRO846 polypeptides |
| 02/10/2009 | US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof |
| 02/10/2009 | US7488792 Peptides; antitumor agents; anticancer agents |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488586 PRO4409 polypeptides |
| 02/10/2009 | US7488583 Fragment complementation assays for G-protein-coupled receptors and their signaling pathways |
| 02/10/2009 | US7488488 Polypeptide, polynucleotide, vector, transformant, antibody, vaccine, and receptor binding assay; miticide vaccines or prophylactic and preventitive vaccines for piroplasmosis, Q fever, or viral encephalitis |
| 02/10/2009 | US7488486 Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof |
| 02/10/2009 | US7488478 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 02/10/2009 | US7488477 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 02/10/2009 | US7488475 Antibody therapy of tumors |
| 02/10/2009 | CA2441187C Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2331368C Nucleic acid vaccines for prevention of flavivirus infection |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce) |
| 02/05/2009 | WO2009018441A1 Anti-cd28 antibodies for prolonging graft survival and treating type 1 diabetes |
| 02/05/2009 | WO2009018411A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | WO2009018386A1 Multispecific epitope binding proteins and uses thereof |
| 02/05/2009 | WO2009018226A2 Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (cd49e) |
| 02/05/2009 | WO2009017823A2 A fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 02/05/2009 | WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein |
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009016839A1 Method for measurement of concentration of antigen |
| 02/05/2009 | WO2009016639A2 Multimeric multiepitope influenza vaccines |